- Home
- TIL vs NTRB Comparison
TIL vs NTRB Comparison
Compare TIL & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- NTRB
- Stock Information
- Founded
- TIL 2018
- NTRB 2016
- Country
- TIL United States
- NTRB United States
- Employees
- TIL N/A
- NTRB N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- NTRB Industrial Specialties
- Sector
- TIL Health Care
- NTRB Health Care
- Exchange
- TIL Nasdaq
- NTRB Nasdaq
- Market Cap
- TIL 230.1M
- NTRB 59.1M
- IPO Year
- TIL 2021
- NTRB N/A
- Fundamental
- Price
- TIL $28.30
- NTRB $9.91
- Analyst Decision
- TIL Buy
- NTRB Buy
- Analyst Count
- TIL 5
- NTRB 1
- Target Price
- TIL $119.00
- NTRB $13.00
- AVG Volume (30 Days)
- TIL 349.6K
- NTRB 126.8K
- Earning Date
- TIL 08-12-2025
- NTRB 05-30-2025
- Dividend Yield
- TIL N/A
- NTRB N/A
- EPS Growth
- TIL N/A
- NTRB N/A
- EPS
- TIL N/A
- NTRB N/A
- Revenue
- TIL N/A
- NTRB $2,398,437.00
- Revenue This Year
- TIL N/A
- NTRB $560.75
- Revenue Next Year
- TIL N/A
- NTRB $588.39
- P/E Ratio
- TIL N/A
- NTRB N/A
- Revenue Growth
- TIL N/A
- NTRB 18.92
- 52 Week Low
- TIL $9.62
- NTRB $3.72
- 52 Week High
- TIL $92.00
- NTRB $11.78
- Technical
- Relative Strength Index (RSI)
- TIL 46.80
- NTRB 69.95
- Support Level
- TIL $20.60
- NTRB $7.52
- Resistance Level
- TIL $25.95
- NTRB $11.68
- Average True Range (ATR)
- TIL 3.47
- NTRB 0.67
- MACD
- TIL -1.29
- NTRB 0.19
- Stochastic Oscillator
- TIL 22.74
- NTRB 62.19
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.